Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A luciferase-based approach for measuring HBGA blockade antibody titers against human norovirus.

Journal of virological methods - 1 Nov 2021

van Loben Sels Jessica M, Meredith Luke W, Sosnovtsev Stanislav V, de Graaf Miranda, Koopmans Marion P G, Lindesmith Lisa C, Baric Ralph S, Green Kim Y, Goodfellow Ian G

Abstract excerpt

BACKGROUND: Noroviruses are the most common cause of viral gastroenteritis worldwide, yet there is a deficit in the understanding of protective immunity. Surrogate neutralization assays have been widely used that measure the ability of antibodies to block virus-like particle (VLP) binding to histo-blood group antigens (HBGAs). However, screening large sample sets against multiple antigens using the traditional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Group Antigens

Share to Genotype

Share to Luciferases

Share to Neutralization Tests

Share to Norovirus

Source

Open in PubMed Open full text

Identifiers

PMID: 34019938
DOI: 10.1016/j.jviromet.2021.114196
PMCID: PMC9924141

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A luciferase-based approach for measuring HBGA blockade antibody titers against human norovirus.PMID 34019938Read ↗

Direct Blockade of the Norovirus Histo-Blood Group Antigen Binding Pocket by NanobodiesSemantic proximity Read ↗

Serological Correlate of Protection against Norovirus‐Induced GastroenteritisSemantic proximity Read ↗

Development of a broad-spectrum therapeutic Fc-nanobody for human norovirusesSemantic proximity Read ↗

Norovirus-specific monoclonal antibodies that block histo-blood group antigen binding isolated from healthy donors.Semantic proximity Read ↗

Identification of a blockade epitope of human norovirus GII.17.Semantic proximity Read ↗

LIPS method for the detection of SARS‐CoV‐2 antibodies to spike and nucleocapsid proteinsSemantic proximity Read ↗

Identification of Human Norovirus GII.3 Blockade Antibody Epitopes.Semantic proximity Read ↗

Blockade Antibody Responses in Human Subjects Challenged with a New Snow Mountain Virus InoculumSemantic proximity Read ↗

Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralizationSemantic proximity Read ↗

Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen-Blocking Antibody Levels.Semantic proximity Read ↗

Llama Nanoantibodies with Therapeutic Potential against Human Norovirus DiarrheaSemantic proximity Read ↗

Broad Blockade Antibody Responses in Human Volunteers after Immunization with a Multivalent Norovirus VLP Candidate Vaccine: Immunological Analyses from a Phase I Clinical TrialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.